Clal Insurance Enterprises (CLIS) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
10 Nov, 2026Executive summary
9M 2024 comprehensive income was NIS 596m vs NIS 205m; income attributable to shareholders was NIS 591m vs NIS 203m, supported by stronger investment returns and insurance underwriting.
Q3 comprehensive income was NIS 274m vs NIS 150m; income attributable to shareholders was NIS 271m vs NIS 151m.
Results reflected higher P&C and health underwriting income and continued credit-card profitability, alongside weaker life-savings results.
Strategy continued shifting toward a diversified financial group, combining insurance and long-term savings with credit cards and agencies.
Financial highlights
9M revenue was NIS 19.906bn vs NIS 15.277bn; investment and finance income rose to NIS 10.792bn from NIS 6.049bn.
9M net income was NIS 387m vs NIS 41m; income attributable to shareholders was NIS 382m vs NIS 39m, with basic EPS of NIS 4.83 vs NIS 0.50.
9M premiums, contributions and investment-contract proceeds totaled NIS 19.8bn vs NIS 20.1bn; premiums and contributions were NIS 19.2bn.
Assets under management reached NIS 361bn at September 30, up from NIS 338bn at December 31, 2023; shareholders’ equity was NIS 9.18bn.
Insurance and savings comprehensive income excluding reserve financial effects was NIS 377m vs NIS 62m; reserve financial effects were NIS 109m vs NIS 344m.
Segment performance
P&C gross premiums rose 10% to NIS 3.154bn; comprehensive income increased to NIS 431m from NIS 219m, reflecting improved underwriting.
Health gross premiums rose 6% to NIS 1.381bn; comprehensive income was NIS 120m vs a NIS 3m loss, reflecting individual-line underwriting improvement and LTC reserve releases.
Life insurance comprehensive income was a NIS 107m loss vs NIS 105m income; long-term savings pretax comprehensive income fell NIS 215m to a NIS 64m loss, mainly due to lower life-insurance interest-rate effects.
Max 9M net income was NIS 210m vs NIS 207m and pretax income was NIS 309m vs NIS 237m; domestic turnover growth partly offset weaker overseas activity.
Pension contributions rose 7% to NIS 7.796bn; provident contributions were NIS 3.395bn vs NIS 3.360bn. Other-segment pretax comprehensive income rose 53% to NIS 52m.
Latest events from Clal Insurance Enterprises
- Markets and P&C gains restored profitability, while health reserves and war uncertainty weighed.CLIS
Q1 2024 - H1 returned to profit on stronger underwriting and card results despite weak markets.CLIS
Q2 2024 - 2024 comprehensive income rose to NIS 956m as insurance and MAX expanded earnings.CLIS
Q4 2024 - Q1 earnings rose on stronger underwriting and Max, amid market and war-related uncertainty.CLIS
Q1 2025 - H1 core income rose modestly as strong insurance results met Q2 softness and a VAT provision.CLIS
Q2 2025 - 9M earnings and AUM grew, with results absorbing a one-off VAT provision.CLIS
Q3 2025 - Core income rose 12%; 2025 dividend reached NIS 400M.CLIS
Q4 2025 - Core income rose 13% as insurance and savings growth lifted Q1 results.CLIS
Q1 2026 - H1 earnings and AUM grew, alongside NIS 200M buyback and dividend plans.CLIS
Q2 2026